Pregnant women's and policymakers' preferences for the expansion of noninvasive prenatal screening: A discrete choice experiment approach study

被引:3
作者
Nguyen, Hung Manh [1 ]
Baradaran, Mohammad [2 ]
Daigle, Gaetan [3 ]
Nshimyumukiza, Leon [4 ,5 ]
Guertin, Jason Robert [1 ,6 ]
Reinharz, Daniel [1 ]
机构
[1] Univ Laval, Dept Med Sociale & Prevent, 1050 Ave Med, Quebec City, PQ G1V 0A6, Canada
[2] Univ Laval, Dept Genie Elect & Genie Informat, Quebec City, PQ, Canada
[3] Univ Laval, Dept Math & Stat, Quebec City, PQ, Canada
[4] Inst Natl Excellence Sante & Serv Sociaux, Quebec City, PQ, Canada
[5] Univ Laval, Fac Sci Infirmieres, Quebec City, PQ, Canada
[6] Univ Laval, Ctr Rech, CHU Quebec, Quebec City, PQ, Canada
基金
加拿大健康研究院;
关键词
discrete choice experiment; health technology assessment; policymakers; pregnant women; HEALTH-CARE PROFESSIONALS; STATED-PREFERENCES; DOWN-SYNDROME; DECISION-MAKERS; VALIDITY; TESTS; VIEWS;
D O I
10.1002/hsr2.1516
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background and Aims: Quantitative approaches for eliciting preferences for new interventions are mostly conducted by patients and rarely by policymakers. This study aimed to quantify the preferences of pregnant women and policymakers regarding the addition of a new test to prenatal screening programs for detecting chromosomal abnormalities. Methods: A discrete choice experiment was conducted to measure the respondents' preferences for a new prenatal test. A seven-attribute instrument was built based on interviews with pregnant women and policymakers. The data were analyzed using robust conditional logistic regression and nested logit models. Results: In total, 272 pregnant women and 24 policymakers completed the questionnaire (response rates of 48% and 55%, respectively). Overall, all attributes were statistically significant in the pregnant women group, whereas only three attributes (test performance, degree of test result certainty, and cost) were statistically significant in the policymakers group. Statistically significant differences in test performance and information were observed between the two groups. Conclusion: Policymakers differed from pregnant women in their appraisal of attributes related to their preference for a new prenatal screening intervention. The low response rates observed in both groups suggest that further investigation of the relevance of this approach must be conducted.
引用
收藏
页数:13
相关论文
共 44 条
[1]   Public and decision-maker stated preferences for pharmaceutical subsidy decisions in Iran: an application of the discrete choice experiment [J].
Afsharmanesh, Gita ;
Rahimi, Farimah ;
Zarei, Leila ;
Peiravian, Farzad ;
Mehralian, Gholamhossein .
JOURNAL OF PHARMACEUTICAL POLICY AND PRACTICE, 2021, 14 (01)
[2]  
[Anonymous], 1984, CAN HLTH ACT
[3]   Evaluation of preferences of women and healthcare professionals in Singapore for implementation of noninvasive prenatal testing for Down syndrome [J].
Barrett, Angela Natalie ;
Advani, Henna Vishal ;
Chitty, Lyn S. ;
Su, Lin Lin ;
Biswas, Arijit ;
Tan, Wei Ching ;
Hill, Melissa ;
Choolani, Mahesh .
SINGAPORE MEDICAL JOURNAL, 2017, 58 (06) :298-310
[4]  
Battaglia A., 2008, GENEREVIEWS, P15
[5]   Women's and healthcare professionals' preferences for prenatal testing: a discrete choice experiment [J].
Beulen, Lean ;
Grutters, Janneke P. C. ;
Faas, Brigitte H. W. ;
Feenstra, Ilse ;
Groenewoud, Hans ;
van Vugt, John M. G. ;
Bekker, Mireille N. .
PRENATAL DIAGNOSIS, 2015, 35 (06) :549-557
[6]   Sequencing of Circulating Cell-free DNA during Pregnancy [J].
Bianchi, Diana W. ;
Chiu, Rossa W. K. .
NEW ENGLAND JOURNAL OF MEDICINE, 2018, 379 (05) :464-473
[7]  
Bridges John F P, 2003, Appl Health Econ Health Policy, V2, P213
[8]   Conjoint Analysis Applications in Health-a Checklist: A Report of the ISPOR Good Research Practices for Conjoint Analysis Task Force [J].
Bridges, John F. P. ;
Hauber, A. Brett ;
Marshall, Deborah ;
Lloyd, Andrew ;
Prosser, Lisa A. ;
Regier, Dean A. ;
Johnson, F. Reed ;
Mauskopf, Josephine .
VALUE IN HEALTH, 2011, 14 (04) :403-413
[9]   Including Opt-Out Options in Discrete Choice Experiments: Issues to Consider [J].
Campbell, Danny ;
Erdem, Seda .
PATIENT-PATIENT CENTERED OUTCOMES RESEARCH, 2019, 12 (01) :1-14
[10]  
Canadian Agency for Drugs and Technologies in Health, 2017, Guidelines for the Economic Evaluation of Health Technologies: Canada, V4th